Norway Pharmaceutical Manufacturing Market Size & Outlook

Name: Norway Pharmaceutical Manufacturing Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The pharmaceutical manufacturing market in Norway is expected to reach a projected revenue of US$ 3,320.6 million by 2030. A compound annual growth rate of 7.7% is expected of Norway pharmaceutical manufacturing market from 2024 to 2030.

Norway pharmaceutical manufacturing molecule type outlook (Revenue, USD million, 2018-2030)
- Biologics & Biosimilars (Large Molecules)
  - Monoclonal Antibodies
  - Vaccines
  - Cell & Gene Therapy
  - Others
- Conventional Drugs (Small Molecules)
Norway pharmaceutical manufacturing drug development type outlook (Revenue, USD million, 2018-2030)
- Outsource
- In-house
Norway pharmaceutical manufacturing formulation outlook (Revenue, USD million, 2018-2030)
- Tablets
- Capsules
- Injectables
- Sprays
- Suspensions
- Powders
- Other Formulations
Norway pharmaceutical manufacturing routes of administration outlook (Revenue, USD million, 2018-2030)
- Oral
- Topical
- Parenterals
- Inhalations
- Other Routes of Administration
Norway pharmaceutical manufacturing therapy area outlook (Revenue, USD million, 2018-2030)
- Cardiovascular Diseases
- Pain
- Diabetes
- Cancer
- Respiratory Diseases
- Other Diseases
Norway pharmaceutical manufacturing prescription requirements outlook (Revenue, USD million, 2018-2030)
- Prescription Medicines
- Over-the-counter (OTC) Medicines
Norway pharmaceutical manufacturing age type outlook (Revenue, USD million, 2018-2030)
- Children & Adolescents
- Adults
- Geriatric
Norway pharmaceutical manufacturing sales channel outlook (Revenue, USD million, 2018-2030)
- Retail
- Non-retail

Norway Pharmaceutical Manufacturing Market Size & Outlook

Sign up - it's easy, and free!